Correlation Between MagnaChip Semiconductor and Mineralys Therapeutics,

Can any of the company-specific risk be diversified away by investing in both MagnaChip Semiconductor and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MagnaChip Semiconductor and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MagnaChip Semiconductor and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on MagnaChip Semiconductor and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MagnaChip Semiconductor with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of MagnaChip Semiconductor and Mineralys Therapeutics,.

Diversification Opportunities for MagnaChip Semiconductor and Mineralys Therapeutics,

-0.53

Correlation Coefficient

MagnaChip Semiconductor  Mineralys Therapeutics,

Excellent diversification

The 3 months correlation between MagnaChip and Mineralys is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding MagnaChip Semiconductor and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and MagnaChip Semiconductor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MagnaChip Semiconductor are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of MagnaChip Semiconductor i.e., MagnaChip Semiconductor and Mineralys Therapeutics, go up and down completely randomly.

Pair Corralation between MagnaChip Semiconductor and Mineralys Therapeutics,

Allowing for the 90-day total investment horizon MagnaChip Semiconductor is expected to generate 12.64 times less return on investment than Mineralys Therapeutics,. But when comparing it to its historical volatility, MagnaChip Semiconductor is 2.2 times less risky than Mineralys Therapeutics,. It trades about 0.02 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  1,206  in Mineralys Therapeutics, Common on December 21, 2024 and sell it today you would earn a total of  467.00  from holding Mineralys Therapeutics, Common or generate 38.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

MagnaChip Semiconductor  vs.  Mineralys Therapeutics, Common

MagnaChip Semiconductor

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in MagnaChip Semiconductor are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, MagnaChip Semiconductor is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Mineralys Therapeutics,

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with MagnaChip Semiconductor and Mineralys Therapeutics,

The main advantage of trading using opposite MagnaChip Semiconductor and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MagnaChip Semiconductor position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.

The idea behind MagnaChip Semiconductor and Mineralys Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.